Hemera DRC A Phase 2 Multi-Center Trial Evaluating Intravitreal AAVCAGsCD59 Compared to Sham Injection for the Treatment of Advanced Dry Age-Related Macular Degeneration with Geographic Atrophy
Research Grant
Administered By
Ophthalmology
Awarded By
Hemera Biosciences
Start Date
January 16, 2020
End Date
July 27, 2021
Administered By
Ophthalmology
Awarded By
Hemera Biosciences
Start Date
January 16, 2020
End Date
July 27, 2021